See more : SunLink Health Systems, Inc. (SSY) Income Statement Analysis – Financial Results
Complete financial analysis of AdaptHealth Corp. (AHCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AdaptHealth Corp., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- SHIVA SUITINGS LTD. (SHVSUIT.BO) Income Statement Analysis – Financial Results
- Home Position Co., Ltd. (2999.T) Income Statement Analysis – Financial Results
- Accredited Solutions, Inc. (ASII) Income Statement Analysis – Financial Results
- The Pegasus Companies, Incorporated (PEGX) Income Statement Analysis – Financial Results
- Ashoka Buildcon Limited (ASHOKA.BO) Income Statement Analysis – Financial Results
AdaptHealth Corp. (AHCO)
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.20B | 2.97B | 2.45B | 1.06B | 529.64M | 345.28M | 192.56M | 174.32M |
| Cost of Revenue | 2.72B | 2.55B | 2.01B | 895.16M | 439.85M | 285.20M | 162.90M | 158.69M |
| Gross Profit | 479.56M | 417.43M | 445.61M | 161.23M | 89.80M | 60.08M | 29.66M | 15.63M |
| Gross Profit Ratio | 14.99% | 14.05% | 18.15% | 15.26% | 16.95% | 17.40% | 15.40% | 8.96% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 310.00K | 0.00 |
| General & Administrative | 190.09M | 162.13M | 167.51M | 89.35M | 56.49M | 1.04M | 9.00M | 8.00M |
| Selling & Marketing | 0.00 | 19.20M | 18.50M | 5.30M | -12.13M | 1.79M | 482.74K | 399.23K |
| SG&A | 190.09M | 162.13M | 167.51M | 89.35M | 44.36M | 1.04M | 693.00 | 11.40M |
| Other Expenses | 887.87M | 64.89M | 52.50M | -2.90M | 135.00K | 197.59K | 0.00 | 0.00 |
| Operating Expenses | 1.16B | 227.02M | 220.01M | 86.44M | 44.36M | 1.23M | 693.00 | 13.30M |
| Cost & Expenses | 3.80B | 2.78B | 2.23B | 981.60M | 157.70M | 1.23M | 693.00 | 171.99M |
| Interest Income | 0.00 | 109.41M | 95.20M | 41.43M | 39.30M | 4.15M | 0.00 | 5.76M |
| Interest Expense | 130.30M | 109.41M | 95.20M | 41.43M | 13.26M | 4.15M | 0.00 | 0.00 |
| Depreciation & Amortization | 420.59M | 423.44M | 333.18M | 82.45M | 62.57M | 50.61M | 27.82M | 26.56M |
| EBITDA | -171.09M | 630.76M | 483.66M | -82.17M | 110.30M | 80.85M | 43.90M | 28.89M |
| EBITDA Ratio | -5.35% | 18.22% | 19.63% | -1.19% | 7.00% | -0.36% | 0.00% | 16.57% |
| Operating Income | -598.40M | 190.41M | 225.61M | 74.79M | 29.70M | -1.23M | -690.00 | 2.32M |
| Operating Income Ratio | -18.70% | 6.41% | 9.19% | 7.08% | 5.61% | -0.36% | 0.00% | 1.33% |
| Total Other Income/Expenses | -125.38M | -92.51M | -34.65M | -277.39M | -51.24M | -8.85M | 0.00 | -5.76M |
| Income Before Tax | -723.78M | 97.90M | 190.96M | -70.67M | 12.53M | 2.92M | -693.00 | -3.44M |
| Income Before Tax Ratio | -22.62% | 3.30% | 7.78% | -6.69% | 2.37% | 0.84% | 0.00% | -1.97% |
| Income Tax Expense | -49.00M | 24.77M | 32.81M | -11.96M | 294.00K | 829.81K | 248.81K | 208.45K |
| Net Income | -678.90M | 69.32M | 156.18M | -58.72M | 12.24M | 2.09M | -693.00 | -3.79M |
| Net Income Ratio | -21.21% | 2.33% | 6.36% | -5.56% | 2.31% | 0.60% | 0.00% | -2.18% |
| EPS | -5.32 | 0.52 | 1.12 | -1.12 | 0.54 | 0.07 | 0.00 | -0.12 |
| EPS Diluted | -5.31 | 0.50 | 0.67 | -1.12 | 0.54 | 0.07 | 0.00 | -0.12 |
| Weighted Avg Shares Out | 134.16M | 134.18M | 133.03M | 52.48M | 22.46M | 31.25M | 31.25M | 31.25M |
| Weighted Avg Shares Out (Dil) | 134.42M | 138.99M | 133.03M | 52.49M | 22.56M | 31.25M | 31.25M | 31.25M |
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ: AHCO). The settlement provides for a fund of $51,000,000...
AdaptHealth Corp. to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Goldman Sachs 45th Annual...
AdaptHealth Corp. to Participate in the Jefferies Global Healthcare Conference
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Jefferies Global Healthcare Conference,...
AdaptHealth Corp. to Participate in the UBS Healthcare Services Cape Cod Summit
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the UBS Healthcare Services Cape...
AdaptHealth Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that AdaptHealth granted restricted stock units covering 553,251 shares of...
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
3 High-Potential Stocks to Buy at Rock-Bottom Prices
Finding investing opportunities in the market might be challenging. Nevertheless, three equities stick out due to their ability to yield large profits during volatility.
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
AdaptHealth Is Too Strong To Be Valued At 40% Of Revenues
AdaptHealth came public in 2019 through a SPAC merger and has been in the penalty box as other SPACS crashed the past 2 years. Yet earnings are growing rapidly and revenues are also steadily growing. Earnings strength has been masked...
AdaptHealth Corp. to Participate in the BofA Securities 2024 Health Care Conference
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, and Jason Clemens,...
Source: https://incomestatements.info
Category: Stock Reports